Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c) or Section
240.14a-12

GENUS, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Its Charter)

________________________________________________________________________________
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

(1) Title of each class of securities to which transaction applies:
_________________________________________________________________
(2) Aggregate number of securities to which transaction applies:
_________________________________________________________________
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined:
_________________________________________________________________
(4) Proposed maximum aggregate value of transaction:________________
(5) Total fee paid: _______________________________________________

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:__________________________________________
(2) Form, Schedule or Registration Statement No.:____________________
(3) Filing Party:____________________________________________________
(4) Date Filed:______________________________________________________

GENUS, INC.

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD ON JUNE 10, 2004

TO THE SHAREHOLDERS:

NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of Genus,
Inc. (the "Company") will be held on Thursday, June 10, 2004 at 10:00 a.m.,
local time, at the Company's principal executive offices located at 1139
Karlstad Drive, Sunnyvale, California 94089, for the following purposes:

1. To elect directors to serve for the ensuing year and until their
successors are elected.

2. To ratify the appointment of PricewaterhouseCoopers LLP as independent
auditors of the Company's financial statements for the fiscal year
ending December 31, 2004.

3. To transact such other business as may properly come before the
meeting or any adjournment thereof. The foregoing items of business
are more fully described in the Proxy Statement accompanying this
Notice.

Only shareholders of record at the close of business on April 14, 2004 are
entitled to vote at the meeting.

All shareholders are cordially invited to attend the meeting in person.
However, to ensure your representation at the meeting you are urged to mark,
sign, date, and return the enclosed proxy card as promptly as possible in the
self-addressed stamped envelope enclosed for that purpose. Any shareholder
attending the meeting may vote in person even if he or she returned a proxy.

THE BOARD OF DIRECTORS

WILLIAM W.R. ELDER
Chairman of the Board, President and
Chief Executive Officer
Sunnyvale, California
April 29, 2004

TABLE OF CONTENTS
-----------------

Information Concerning Solicitation and Voting. . . . . . . . . . . . . . . . 1

Proposal One: Election of Directors . . . . . . . . . . . . . . . . . . . . . 4

Audit Committee Report. . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Executive Officer Compensation. . . . . . . . . . . . . . . . . . . . . . . . 10

Compensation Committee Report . . . . . . . . . . . . . . . . . . . . . . . . 13

Proposal Two: Ratify Appointment of Independent Auditors . . . . . . . . . . 16

GENUS, INC.

PROXY STATEMENT FOR THE 2004 ANNUAL MEETING OF SHAREHOLDERS

The enclosed Proxy is solicited on behalf of the Board of Directors of
Genus, Inc., a California corporation (the "Company"), for use at the Annual
Meeting of Shareholders (the "Annual Meeting") to be held on Thursday, June 10,
2004 at 10:00 a.m., local time, or at any adjournment thereof, for the purposes
set forth herein and in the accompanying Notice of Annual Meeting of
Shareholders. The Annual Meeting will be held at the Company's principal
executive offices located at 1139 Karlstad Drive in Sunnyvale, California 94089.
The Company's telephone number at that location is (408) 747-7120.

These proxy solicitation materials were mailed on or about April 29, 2004
to all shareholders entitled to vote at the meeting.

INFORMATION CONCERNING SOLICITATION AND VOTING

RECORD DATE AND SHARE OWNERSHIP

Shareholders of record at the close of business on April 14, 2004 (the
"Record Date") are entitled to notice of and to vote at the Annual Meeting. At
the Record Date, 39,662,451 shares of the Company's common stock, no par value,
were issued and outstanding.

VOTING

Each share of common stock outstanding on the Record Date is entitled to
one vote. In addition, each shareholder on the Record Date, or his or her
proxy, may cumulate such shareholder's votes and give one candidate a number of
votes equal to the number of directors to be elected multiplied by the number of
shares held by such shareholder, or distribute the shareholder's votes on the
same principle among as many candidates as the shareholder may select, provided
that votes cannot be cast for more than five candidates. No shareholder or
proxy, however, shall be entitled to cumulate votes for a candidate unless such
candidate's name has been placed in nomination prior to the voting and the
shareholder, or any other shareholder, has given notice at the meeting, prior to
the voting, of the shareholder's intention to cumulate votes. If any
shareholder gives such notice, all shareholders may cumulate their votes for
candidates in nomination.

QUORUM; ABSTENTIONS; BROKER NON-VOTES

The affirmative vote of a majority of the Votes Cast will be required under
California law to approve the proposals in this Proxy Statement. For this
purpose, the "Votes Cast" are defined under California law to be the shares of
the Company's common stock represented and "voting" at the Annual Meeting. In
addition, the affirmative votes must constitute at least a majority of the
required quorum, which quorum is a majority of the shares outstanding on the
Record Date. Votes that are cast against the proposal will be counted for
purposes of determining (i) the presence or absence of a quorum and (ii) the
total number of Votes Cast with respect to the proposal.

While there is no definitive statutory or case law authority in California
as to the proper treatment of abstentions in the counting of votes with respect
to a proposal, the Company believes that abstentions should be counted for
purposes of determining both (i) the presence or absence of a quorum and (ii)
the total number of Votes Cast with respect to the proposal. In the absence of
controlling precedent to the contrary, the Company intends to treat abstentions
in this manner. Accordingly, abstentions will have the same effect as a vote
against the proposal. Broker non-votes will be counted for purposes of
determining the presence or absence of a quorum, but will not be counted for
purposes of determining the number of Votes Cast with respect to the proposal.

REVOCABILITY OF PROXIES

Any proxy given pursuant to this solicitation may be revoked by the person
giving it at any time before its use by delivering to the Company (Attention:
Shum Mukherjee, Chief Financial Officer) a written notice of revocation or a
duly executed proxy bearing a later date or by attending the meeting and voting
in person.

SOLICITATION

This Proxy Statement is furnished in connection with the solicitation of
proxies by Genus, Inc. on behalf of the Board of Directors for the 2004 Annual
Meeting of Shareholders. The cost of soliciting proxies will be borne by the
Company. The Company may reimburse brokerage firms and other persons
representing beneficial owners of shares for their expenses in forwarding
solicitation material to such beneficial owners. Proxies may be solicited by
certain of the Company's directors, officers and regular employees, without
additional compensation, personally or by telephone, telegram or facsimile.

DEADLINE FOR RECEIPT OF SHAREHOLDER PROPOSALS

Shareholders who intend to present a proposal for inclusion in the
Company's proxy materials for the 2005 Annual Meeting of Shareholders must
submit the proposal to the Company no later than December 31, 2004.
Additionally, shareholders who intend to present a proposal at the 2005 Annual
Meeting of Shareholders without inclusion of such proposal in the Company's
proxy materials for the 2005 Annual Meeting must provide notice of such proposal
to the Company no later than December 31, 2004. The Company reserves the right
to reject, rule out of order, or take other appropriate action with respect to
any proposal that does not comply with these and other applicable requirements.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information known to the Company
regarding beneficial ownership of the Company's common stock as of March 31,
2004 by (i) each of the Company's directors, (ii) each executive officer named
in the Summary Compensation Table appearing herein, (iii) all directors and
executive officers of the Company as a group, and (iv) each person known by the
Company to beneficially own more than 5% of the Company's common stock:

NUMBER OF PERCENT OF
NAME AND ADDRESS OF BENEFICIAL OWNER** SHARES(1) CLASS(2)
- ----------------------------------------------------------- -------------- ----------

William W.R. Elder. . . . . . . . . . . . . . . . . . . . . 642,795 (3) 1.61%
Thomas E. Seidel. . . . . . . . . . . . . . . . . . . . . . 157,378 (4) *
Mario M. Rosati . . . . . . . . . . . . . . . . . . . . . . 64,235 (5) *
G. Frederick Forsyth. . . . . . . . . . . . . . . . . . . . 35,000 (6) *
Todd S. Myhre . . . . . . . . . . . . . . . . . . . . . . . 75,535 (7) *
Robert J. Richardson. . . . . . . . . . . . . . . . . . . . 35,000(8) *
Edward C. Lee+. . . . . . . . . . . . . . . . . . . . . . . 0 *
Shum Mukherjee. . . . . . . . . . . . . . . . . . . . . . . 189,933(9) *
Werner Rust+. . . . . . . . . . . . . . . . . . . . . . . . 0 *
All directors and executive officers as a group (9 persons) 1,199,876 (10) 2.97%

<FN>
* Less than 1%.

** Except as indicated otherwise, the address is: c/o Genus, Inc., 1139 Karlstad Drive,
Sunnyvale, CA 94089.

+ As of March 31, 2004, these individuals are no longer affiliated with Genus.

(1) Except as otherwise indicated in the footnotes to this table and pursuant
to applicable community property laws, the persons named in the table have
sole voting and investment power with respect to all shares of common stock
shown as beneficially owned by them.

(2) Applicable percentage ownership is based on 39,625,284 shares of common
stock outstanding as of March 31, 2004 together with applicable options for
such shareholder. Beneficial ownership is determined in accordance with the
rules of the Securities and Exchange Commission, based on factors including
voting and investment power with respect to shares. Shares of common stock
subject to the options currently exercisable, or exercisable within 60 days
of March 31, 2004, are deemed outstanding for computing the percentage
ownership of the person holding such options, but are not deemed
outstanding for computing the percentage ownership of any other person.

(3) Consists of 279,350 shares held by William W.R. Elder, 75,000 shares by
Elder Family Trust and of options to purchase 288,445 shares of common
stock exercisable within 60 days of March 31, 2004.

(4) Consists of 31,128 shares of common stock held by Mr. Seidel and of options
to purchase 126,250 shares of common stock exercisable within 60 days of
March 31, 2004.

(5) Consists of 23,500 shares of common stock held by Mr. Rosati, of 1,500
shares of common stock held by Mario Rosati Trust, of 3,500 shares of
common stock held by Mr. Rosati's spouse, of options to purchase 35,000
shares of common stock exercisable within 60 days of March 31, 2004, and of
735 shares held by Mr. Rosati through his proportionate partnership
interest in WS Investment Company holdings.

(6) Consists of Mr. Forsyth's options to purchase 35,000 shares of common stock
exercisable within 60 days of March 31, 2004.

(7) Consists of 35,535 shares of common stock held by Mr. Myhre and of options
to purchase 40,000 shares of common stock exercisable within 60 days of
March 31, 2004.

(8) Consists of Mr. Richardson's options to purchase 35,000 shares of common
stock exercisable within 60 days of March 31, 2004.

(9) Consists of 21,128 shares of common stock held by Mr. Mukherjee and options
to purchase 168,805 shares of common stock exercisable within 60 days of
March 31, 2004.

(10) Consists of shares held and of options to purchase common stock exercisable
within 60 days of March 31, 2004.

PROPOSAL ONE

ELECTION OF DIRECTORS

NOMINEES

The Company's Bylaws provide for a variable board of four to seven
directors, with the number currently fixed at five. Unless otherwise instructed,
the proxy holders will vote the proxies received by them for the Company's five
nominees named below, all of whom are presently directors of the Company. In the
event that any nominee of the Company is unable or declines to serve as a
director at the time of the Annual Meeting, the proxies will be voted for any
nominee who shall be designated by the present Board of Directors to fill the
vacancy. It is not expected that any nominee listed below will be unable or will
decline to serve as a director. In the event that additional persons are
nominated for election as directors, the proxy holders intend to vote all
proxies received by them in such a manner in accordance with cumulative voting
as will assure the election of as many of the nominees listed below as possible,
and, in such event, the specific nominees to be voted for will be determined by
the proxy holders. The term of office of each person elected as a director will
continue until the next Annual Meeting of Shareholders or until his successor
has been elected and qualified.

The names of the nominees, and certain information about them, are set
forth below.

DIRECTOR
NAME OF NOMINEE AGE PRINCIPAL OCCUPATION SINCE
- -------------------- --- ------------------------------------------- --------

William W.R. Elder 65 Chairman of the Board, President and Chief 1981
Executive Officer of the Company

Todd S. Myhre 59 President and CEO of Ybrain.com 1994

G. Frederick Forsyth 59 President and CEO of NewRoads, Inc. 1996

Mario M. Rosati 57 Member of Wilson Sonsini Goodrich & Rosati, 1981
Professional Corporation

Robert J. Richardson 58 Business Consultant 2000

Except as set forth below, each of the nominees has been engaged in his
principal occupation set forth above during the past five years. There are no
family relationships among any directors or executive officers of the Company.

William W.R. Elder was a founder of Genus and is our Chairman of the Board,
President and our Chief Executive Officer. From October 1996 to April 1998, Dr.
Elder served only as Chairman of the Board. From April 1990 to September 1996,
Dr. Elder was Chairman of the Board, President and Chief Executive Officer of
the Company. From November 1981 to April 1990, Dr. Elder was President and a
director of the Company. Mr. Elder is also a director of Aehr Test Systems,
Inc.

Mario M. Rosati has served as a director since our inception in November
1981. He has been an attorney affiliated with the law firm Wilson Sonsini
Goodrich & Rosati, Professional Corporation, general counsel to the Company,
since 1971 and a member of the firm since 1975. Mr. Rosati is also a director
of Aehr Test Systems, a manufacturer of computer hardware testing systems,
Sanmina-SCI Corporation, an electronics contract manufacturer, Symyx
Technologies, Inc., a combinatorial materials science company, and Vivus, a
specialty pharmaceutical company, all publicly-held companies. He is also a
director of a number of privately held companies.

Todd S. Myhre has served as a director since August 1993. Since September
1999, he served as Chief Executive Officer and a Board member for Ybrain.com, an
eCommerce company focused on the college student market. From February 1998 to
August 1999 and from September 1995 to January 1996, he served as President,
Chief Executive Officer, and a Board member of GameTech International, an
electronic gaming manufacturer. From January 1996 to January 1998, Mr Myhre was
an international business consultant. From January 1993 to December 1994, from
August 1993 to December 1993, and from July 1994 to August 1995, Mr. Myhre
served as Chief Financial Officer of the Company, Vice President and Chief
Operating Officer of the Company, and President and Chief Operating Officer of
the Company, respectively. Mr. Myhre has also served as a director of Epac,
Inc. since January 2002.

G. Frederick Forsyth has served as a director since February 1996. Since
August 2003, Mr. Forsyth has served as the Chief Operating Officer of LeapFrog
Enterprises. From May 2000 to May 2003, Mr. Forsyth has served as the President
and CEO of NewRoads, Inc. From March 1999 to May 2000, Mr. Forsyth served as
President of Americas for Solectron Corp. From August 1997 to March 1999, Mr.
Forsyth served as President, Professional Products Division of Iomega, Inc.
From June 1989 to February 1997, Mr. Forsyth was associated with Apple Computer,
Inc., a personal computer manufacturer, in various senior management positions,
most recently as Senior Vice President and General Manager, Macintosh Product
Group.

Robert J. Richardson has served as a director since March 2000. Mr.
Richardson has served as a semiconductor industry consultant since January 2000.
Mr. Richardson is also a director of Applied Signal Technology, Inc., a provider
of advanced digital signal processing products, systems, and services used in
reconnaissance of telecommunication signals. From November 1997 to January
2000, Mr. Richardson served as Chairman, Chief Executive Officer and President
of Unitrode Corporation. From June 1992 to November 1997, he served in various
positions at Silicon Valley Group, Inc. including President Lithography Systems,
President Track Systems Division, and Corporate Vice-President New Business
Development and Marketing. From October 1988 to June 1992, Mr. Richardson was
President and General Manager, Santa Cruz Division at Plantronics, Inc.

VOTE REQUIRED

If a quorum is present, the nominees receiving the highest number of votes
will be elected to the Board of Directors. Abstentions and broker non-votes
will have no effect on the election of directors.

RECOMMENDATION

THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR THE
ELECTION OF THE NOMINEES.

BOARD MEETINGS AND The Board of Directors held seven meetings during fiscal year 2003. All directors
COMMITTEES attended at least 80% percent of the meetings of the Board of Directors and of the
committees on which they served during fiscal year 2003.

BOARD INDEPENDENCE The Board of Directors has determined that each of its current directors, including
all directors standing for re-election, except the Chief Executive Officer, has no
material relationship with Genus and is independent within the meaning of the
NASDAQ Stock Market, Inc. director independence standards, as currently in
effect and as they may be changed from time to time.

COMMITTEES OF THE BOARD OF The Board of Directors has Audit, Nominating, and Compensation Committees.
DIRECTORS Each of these committees has adopted a written charter. All members of the
committees are appointed by the Board of Directors, and are non-employee
directors. The following describes each committee, its current membership, the
number of meetings held during fiscal year 2003 and its function.

AUDIT COMMITTEE The Audit Committee consists of Messrs. Myhre, Forsyth, and Richardson, each of
whom is independent within the meaning of the NASDAQ Stock Market, Inc.
director independence standards, as currently in effect and as they may be changed
from time to time. The Board of Directors has determined that Messrs. Myhre and
Forsyth are each an "audit committee financial expert" as defined in SEC rules. The
Audit Committee held five meetings during fiscal year 2003. Mr. Myhre serves as
Chairman of the Audit Committee.

The Audit Committee oversees the accounting, financial reporting and audit
processes; makes recommendations to the Board of Directors regarding the
selection of independent auditors; reviews the results and scope of audit and other
services provided by the independent auditors; reviews the accounting principles
and auditing practices and procedures to be used in preparing our financial
statements; and reviews our internal controls.

The Audit Committee works closely with management and our independent
auditors. The Audit Committee also meets with our independent auditors in an
executive session, without the presence of our management, on a quarterly basis,
following completion of their quarterly reviews and annual audit and prior to our
earnings announcements, to review the results of their work. The Audit Committee
also meets with our independent auditors to approve the annual scope of the audit
services to be performed.

The Audit Committee Report is included herein on page 8.

NOMINATING COMMITTEE The Nominating Committee consists of Messrs. Forsyth and Richardson, each of
whom is independent within the meaning of the NASDAQ Stock Market, Inc.
director independence standards, as currently in effect and as they may be changed
from time to time. The Nominating Committee charter is included herein as
Appendix A.

The Nominating Committee held one meeting during fiscal year 2003.

The Nominating Committee considers and periodically reports on matters relating
to the identification, selection and qualification of the Board of Directors and
candidates nominated to the Board of Directors and its committees; develops and
recommends governance principles applicable to us; oversees the evaluation of the
Board of Directors and management; and oversees and sets compensation for the
Board of Directors.

The Nominating Committee considers properly submitted shareholder
recommendations for candidates for membership on the Board of Directors as
described below under "Identification and Evaluation of Nominees for Directors."
In evaluating such recommendations, the Nominating Committee seeks to achieve a
balance of knowledge, experience and capability on the Board of Directors and to
address the membership criteria set forth under "Director Qualifications." Any
shareholder recommendations proposed for consideration by the Nominating
Committee should include the candidate's name and qualifications for membership
on the Board of Directors and should be addressed to our Chief Financial Officer.
In addition, procedures for shareholder direct nomination of directors are discussed
in detail in our bylaws, which will be provided to you upon written request.

DIRECTOR QUALIFICATIONS The Nominating Committee uses a variety of criteria to evaluate the qualifications
and skills necessary for members of our Board of Directors. Under these criteria,
members of the Board of Directors should have the highest professional and
personal ethics and values, consistent with longstanding Genus values and
standards. They should have broad experience at the policy-making level in
business, government, education, technology or public interest. They should be
committed to enhancing shareholder value and should have sufficient time to carry
out their duties and to provide insight and practical wisdom based on experience.
Their service on other boards of public companies should be limited to a number
that permits them, given their individual circumstances, to perform responsibly all
director duties. Each director must represent the interests of all shareholders.

IDENTIFICATION AND EVALUATION OF The Nominating Committee utilizes a variety of methods for identifying and
NOMINEES FOR DIRECTORS evaluating nominees for director. The Nominating Committee regularly assesses the
appropriate size of the Board of Directors, and whether any vacancies on the Board
of Directors are expected due to retirement or otherwise. In the event that vacancies
are anticipated, or otherwise arise, the Nominating Committee considers various
potential candidates for director. Candidates may come to the attention of the
Nominating Committee through current members of the current Board of Directors,
professional search firms, shareholders or other persons. These candidates are
evaluated at regular or special meetings of the Nominating Committee, and may be
considered at any point during the year. As described above, the Nominating
Committee considers properly submitted shareholder recommendations for
candidates for the Board of Directors. In evaluating such recommendations, the
Nominating Committee uses the qualifications standards discussed above and seeks
to achieve a balance of knowledge, experience and capability on the Board of
Directors.

COMPENSATION COMMITTEE The Compensation Committee consists of Messrs. Rosati and Richardson. The
Compensation Committee held three meetings during fiscal year 2003.

The Compensation Committee oversees and makes recommendation to the Board
of Directors regarding our compensation and benefits policies; and oversees,
evaluates and approves compensation plans, policies and programs for our
executive officers.

INTERLOCKS AND INSIDER During fiscal year 2003, no member of the Compensation Committee was an
PARTICIPATION employee of Genus. During fiscal year 2003, no member of the Compensation
Committee or executive officer of Genus served as a member of the Board of
Directors or Compensation Committee of any entity that has an executive officer
serving as a member of our Board of Directors or Compensation Committee.

ANNUAL MEETING ATTENDANCE Although we do not have a formal policy regarding attendance by members of the
Board of Directors at our annual meeting of shareholders, directors are encouraged
to attend annual meetings of Genus shareholders. All directors attended the 2003
annual meeting of shareholders. The Nominating Committee will consider, during
the upcoming year, adopting a formal policy on director attendance at annual
meetings of shareholders.

COMMUNICATING WITH THE BOARD Shareholders may communicate with the Board of Directors by submitting an email
OF DIRECTORS to idunlop@genus.com or by writing to us at Genus, Inc. Attention: Investor
Relations, 1139 Karlstad Drive, Sunnyvale, California 94089. Shareholders who
would like their submission directed to a member of the Board of Directors may so
specify, and the communication will be forwarded, as appropriate.

CODE OF ETHICS The Board of Directors has adopted a Code of Ethics for Principal Executive and
Senior Financial Officers, which is applicable to the Chief Executive Officer, Chief
Financial Officer and any other principal accounting officer. We will provide a
copy of the Code of Ethics upon request made by email to idunlop@genus.com or
in writing toGenus, Inc. Attention: Investor Relations, 1139 Karlstad Drive,
Sunnyvale, California 94089. Genus will disclose any amendment to the Code of
Ethics or waiver of a provision of the Code of Ethics, including the name of the
officer to whom the waiver was granted, on our website atwww.genus.com, on the
Investor Relations page.

DIRECTOR COMPENSATION The Company currently pays to its directors who are not employees a fee of $2,000
per meeting. In addition, the Company pays non-employee members of the board
an annual fee of $15,000. The Company also reimburses directors for reasonable
expenses incurred in attending meetings. Annual option grants to the directors are
discretionary under the Company's 2000 Stock Plan. Options issued to directors are
fully vested upon the date of grant.

AUDIT COMMITTEE REPORT

The Audit Committee of the board of directors of Genus, Inc. serves as
representatives of the board for general oversight of Genus' financial
accounting and reporting system of internal control, audit process and process
for monitoring compliance with laws and regulations. The Audit Committee,
consisting of Myhre, Forsyth and Richardson, held 4 meetings in fiscal year
2003. Each member is an independent director in accordance with the NASDAQ
National Market Audit Committee requirements. The Audit Committee evaluates the
scope of the annual audit, reviews audit results, consults with management and
the Company's independent auditors prior to the presentation of financial
statements to shareholders and, as appropriate, initiates inquiries into aspects
of the Company's financial affairs.

Genus management has primary responsibility for preparing Genus' financial
statements and for Genus' financial reporting process. Genus' independent
auditors, PricewaterhouseCoopers LLP ("PwC"), are responsible for expressing an
opinion on the conformality of Genus' audited financial statements to generally
accepted accounting principles. The Audit Committee has reviewed and discussed
with management the audited financial statements for the year ended December 31,
2003. PwC issued their unqualified report dated March 11, 2004 on the Company's
financial statements.

The Audit Committee has also discussed with PwC the matters required to be
discussed by AICPA Statement on Auditing Standards No. 61, "Communication with
Audit Committees." The Audit committee has also received the written
disclosures and letter from PwC required by Independence Standards Board
Standard No. 1, "Independence Discussions with Audit Committees," and has
conducted a discussion with PwC relative to its independence. The Audit
Committee has considered whether PwC's provision of non-audit services is
compatible with its independence. The Audit Committee has an Audit Committee
Charter which was attached to last year's Proxy Statement.

Based on the reviews and discussions referred to above, the Audit Committee
recommended to the Board of Directors of Genus, Inc. that the Company's audited
financial statements for the fiscal year ended December 31, 2003 be included in
the Annual Report on Form 10-K.

Respectfully submitted by:

Todd S. Myhre, Chairman, Audit Committee
G. Frederick Forsyth, Member, Audit Committee
Robert J. Richardson, Member, Audit Committee

AUDIT FEES

The following table sets forth the aggregate fees billed or to be billed by
PricewaterhouseCoopers LLP for the following services during fiscal years 2002
and 2003:

DESCRIPTION OF SERVICES 2003 2002
- ------------------------------------------ -------- --------

Audit fees (1) . . . . . . . . . . . . . . $375,642 $406,200
Audit-Related Fees(2). . . . . . . . . . . $ 5,250 $ 0
Tax fees (3) . . . . . . . . . . . . . . . $ 28,350 $ 28,400
-------- --------
Total. . . . . . . . . . . . . . . . . . $409,242 $434,600
======== ========

(1) AUDIT FEES: This category consists of fees for the audit of our annual
financial statements, review of the financial statements included in our
quarterly reports on Form 10-Q and services that are normally provided by the
independent auditors in connection with statutory and regulatory filings or
engagements for those fiscal years. This category also includes advice on audit
and accounting matters that arose during, or as a result of, the audit or the
review of interim financial statements, statutory audits required by non-U.S.
jurisdictions and the preparation of an annual "management letter" on internal
control matters.

(2) AUDIT-RELATED FEES: This category consists of assurance and related
services by PricewaterhouseCoopers LLP that are reasonably related to the
performance of the audit or review of our financial statements and are not
reported above under "Audit Fees."

(3) TAX FEES: This category consists of professional services rendered by
PricewaterhouseCoopers LLP for tax compliance and tax planning. The services for
the fees disclosed under this category include tax return preparation and
technical tax advice.

The Company's Audit Committee has considered the provision of the services
described in the footnotes above and deems such services are compatible with the
maintenance of the independent status of PricewaterhouseCoopers LLP.

SECTION 16(A) REPORTS

Section 16(a) of the Securities Exchange Act of 1934 (the "1934 Act")
requires our directors and executive officers, and persons who own more than ten
percent of a registered class of our equity securities, to file with the SEC
initial reports of ownership and reports of changes in ownership of our common
stock and our other equity securities. Officers, directors and greater than ten
percent shareholders are required by SEC regulation to furnish us with copies of
all Section 16(a) forms they file.

To our knowledge, based solely on a review of the copies of such reports
furnished to us and written representations that no other reports were required,
all Section 16(a) filing requirements applicable to its officers, directors and
greater than ten percent beneficial owners were complied with during the fiscal
year ended December 31, 2003.

EXECUTIVE OFFICER COMPENSATION

SUMMARY COMPENSATION TABLE

The following table discloses compensation received by the Company's Chief
Executive Officer and the other most highly compensated executive officers of
the Company (the "Named Executive Officers") for the three fiscal years ended
December 31, 2003, 2002 and 2001:

LONG TERM COMPENSATION
AWARDS
-------------------------------
ANNUAL COMPENSATION SECURITIES
--------------------------------------- UNDERLYING
FISCAL OTHER ANNUAL OPTIONS ALL OTHER
NAME AND PRINCIPAL POSITION YEAR SALARY ($) BONUS ($) COMPENSATION ($) (# OF SHARES) COMPENSATION ($)
------ ---------- --------- ---------------- ------------- ----------------

William W.R. Elder Chairman of the Board, 2003 288,000 0 0 200,000 22,387(1)
President and Chief Executive 2002 288,000 0 0 186,000 25,437(2)
Officer 2001 330,000 0 0 50,000 18,460 (3)

Thomas E. Seidel, Ph.D. 2003 188,800 0 0 0 19,952(4)
Executive Vice President and 2002 180,800 0 0 115,000 22,373(5)
Chief Technical Officer . . . . . . . . . 2001 218,532 0 0 0 24,421(6)

Shum Mukherjee 2003 192,000 0 0 100,000 20,219(7)
Chief Financial Officer 2002 192,000 75,000 0 108,000 17,089(8)
2001 48,000 25,000 0 100,000 3,237 (9)

Edward Lee* 2003 161,500 0 0 0 16,202(10)
Executive Vice President, Advance 2002 161,500 0 0 84,000 13,184(11)
Technology 2001 175,632 0 0 25,000 13,239(12)

Werner Rust* 2003 153,000 13,000 30,311(13) - 18,046(14)
Executive Vice President, 2002 153,000 0 50,000(15) 84,000 18,696(16)
Worldwide Sales & 2001 15,692 0 0 50,000 1,747 (17)
Marketing

<FN>
*These individuals are no longer affiliated with Genus as of March 31, 2004.

(1) Consists of insurance premium of $3,434 for a life insurance policy, car allowance of $13,453, and matched 401(k)
contribution of $5,500.

(2) Consists of insurance premium of $4,245 for a life insurance policy, car allowance of $15,747, and matched 401(k)
contribution of $5,445.

(3) Consists of insurance premiums of $4,910 for a group term life insurance policy, the proceeds of which are payable to
Mr. Elder's named beneficiaries, CPA services allowance of $3,150, life insurance premium of $5,625, and matched
401(k) contribution of $4,775.

(4) Consists of insurance premium of $1,459 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $6,493.

(5) Consists of insurance premium of $4,949 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $5,424.

(6) Consists of insurance premiums of $6,096 for a group term life insurance policy, the proceeds of which are payable to
Dr. Seidel's named beneficiaries, CPA services allowance of $1,075, car allowance of $12,000, and matched 401(k)
contribution of $5,250.

(7) Consists of insurance premium of $1,459 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $6,760.

(8) Consists of insurance premium of $949 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $4,140.

(9) Consists of insurance premiums of $237 for a group term life insurance policy, the proceeds of which are payable to
Mr. Mukherjee's named beneficiaries, and car allowance of $3,000.

(10) Consists of insurance premium of $1,381 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $2,821.

(11) Consists of insurance premium of $781 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $403.

(12) Consists of insurance premiums of $839 for a group term life insurance policy, the proceeds of which were payable to
Mr. Lee's named beneficiaries, and car allowance of $12,400.

(13) Commission paid to Mr. Rust for meeting 2003 sales objectives.

(14) Consists of insurance premium of $2,603 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $3,443

(15) Commission paid to Mr. Rust for meeting 2002 sales objectives.

(16) Consists of insurance premium of $2,106 for a life insurance policy, car allowance of $12,000, and matched 401(k)
contribution of $4,590.

(17) Consists of insurance premiums of $114 for a group term life insurance policy, the proceeds of which were payable to
Mr. Rust's named beneficiaries, car allowance of $1,250, and matched 401(k) contribution of $383.

OPTION/SAR GRANTS IN LAST FISCAL YEAR

The following table provides information on option grants made in fiscal
year 2003 to the Named Executive Officers. No Stock Appreciation Rights ("SARs")
were granted.

POTENTIAL REALIZABLE VALUE
% OF TOTAL AT ASSUMED ANNUAL RATES
NUMBER OF OPTIONS OF STOCK PRICE
SECURITIES GRANTED TO APPRECIATION FOR OPTION
UNDERLYING EMPLOYEES EXERCISE TERM (3)
OPTIONS IN FISCAL PRICE PER EXPIRATION
NAME GRANTED YEAR (1) SHARE ($)(2) DATE 5% ($) 10% ($)
- ------------------ ---------- ----------- ------------- ---------- ---------------- --------------

William W.R. Elder 200,000 17.44% $ 4.08 10/24/13 $ 513,178 $ 1,300,493

Shum Mukherjee 100,000 8.72% $ 4.08 10/24/13 $ 256,589 $ 650,246

Eddie Lee 25,000 2.18% $ 4.08 10/24/13 $ 64,147 $ 162,561
<FN>
(1) Based on an aggregate of 1,146,500 options granted to all employees (including employees at
Korea and Japan subsidiaries) during fiscal year 2003. Options granted in fiscal year 2003 expire from
2007 to 2013 and vest as follows; (i) all options granted prior to October 24, 2003 vest monthly over
three years commencing one month after the date of grant or (ii) all options granted on October 24, 2003
and beyond, vest 6/48th commencing six months from the date of grant and the remainder vest monthly
over the next 42 months.

(2) All options were granted at an exercise price equal to the fair market value based on the
closing market value of common stock on the Nasdaq National Market on the date of grant.

(3) Potential realizable values (i) are net of exercise price before taxes, (ii) assume that the
Common Stock appreciates at the annual rate shown (compounded annually) from the date of grant until the
expiration of the ten-year option term, and (iii) assume that the option is exercised at the exercise
price and sold on the last day of its term at the appreciated price. These numbers are calculated based
on SEC rules and do not reflect our estimate of future stock price growth.

AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END
OPTION/SAR VALUES

The following table provides information on option exercises in fiscal 2003
by the Named Executive Officers and the number and value of such officers'
unexercised options at December 31, 2003. No SARs have been granted.

VALUE OF UNEXERCISED
SHARES VALUE NUMBER OF UNEXERCISED IN-THE-MONEY OPTIONS AT
ACQUIRED ON REALIZED OPTIONS DECEMBER 31, 2003 DECEMBER 31 , 2003 ($)(2)
-------------------------------
NAME EXERCISE (#) ($) (1) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
- ------------------ ------------

William W.R. Elder 0 $ 0 216,778 319,222 $ 626,374 $ 862,911
Thomas E. Seidel . 0 $ 0 110,278 64,722 $ 311,919 $ 273,091
Shum Mukherjee .. 0 $ 0 126,722 181,278 $ 481,111 $ 522,569
Edward Lee . . . . 0 $ 0 76,833 72,167 $ 125,758 $ 236,399
Werner Rust. . . . 0 $ 0 0(3) 0(3) 0(3) 0(3)

<FN>
(1) Market value of underlying securities (based on the fair market value of the Company's common stock on
the Nasdaq National Market) at the time of exercise, minus the exercise price.

(2) Market value of securities underlying in-the-money options at the end of fiscal year 2003 (based on
$6.00 per share, the closing price of Company's common stock on the Nasdaq National Market on
December 31, 2003), less the exercise price.

(3) Werner Rust resigned from the Company in October 2003 and all of his vested and unexercised options
were canceled prior to 12/31/2003

The Company has not established any long-term incentive plans or defined
benefit or actuarial plans covering any of the Named Executive Officers.

CHANGE OF CONTROL AND SEVERANCE ARRANGEMENTS

The Company has entered into a change of control agreement with all executive
staff members of the Company, where upon any change in control, the executive
staff members will be entitled a severance pay ranging from 6 months to one year
and immediate vesting of all options.

William W.R. Elder entered into a change of control severance agreement, which
awards him severance in the amount of $360,000 upon a change of control and his
subsequent termination.

Thomas E. Seidel entered into a change of control severance agreement, which
awards him severance in the amount of $240,000 upon a change of control and his
subsequent termination.

Shum Mukherjee entered into a change of control severance agreement, which
awards him severance in the amount of $180,000 upon a change of control and his
subsequent termination.

COMPENSATION COMMITTEE REPORT

EXECUTIVE COMPENSATION

The objectives of the overall executive compensation program are to
attract, retain, motivate and reward Company executives while aligning their
compensation with the achievements of key business objectives and maximization
of shareholder value.

The Compensation Committee is responsible for:

1. Determining the specific executive compensation methods to be used by
the Company and the participants in each of those specific programs;

2. Determining the evaluation criteria and timelines to be used in those
programs;

3. Determining the processes that will be followed in the ongoing
administration of the programs; and

4. Determining their role in the administration of the programs.

All of the actions take the form of recommendations to the full Board of
Directors where final approval, rejection or redirection will occur. The
Compensation Committee is responsible for administering the compensation
programs for all Company officers. The Compensation Committee has delegated the
responsibility of administering the compensation programs for all other Company
employees to the Company's officers.

Currently, the Company uses the following executive compensation vehicles:

- Cash-based programs: Base salary, Annual Incentive Bonus Plan, Annual
Profit Sharing Plan, and a Sales Incentive Commission Plan; and

- Equity-based programs: 2000 Stock Plan and the 1989 Employee Stock
Purchase Plan.

These programs apply to the Chief Executive Officer and all executive level
positions, except for the Sales Incentive Commission Plan, which only includes
executives directly responsible for sales activities. Periodically, but at least
once near the close of each fiscal year, the Compensation Committee reviews the
existing plans and recommends those that should be used for the subsequent
year.

The criteria for determining the appropriate salary level, bonus and stock
option grants for the Chief Executive Officer and each of the executive officers
include (a) Company performance as a whole, (b) business unit performance (where
appropriate) and (c) individual performance objectives. Company performance and
business unit performance are measured against both strategic and financial
goals. Examples of these goals are to obtain: operating profit, revenue growth,
timely new product introduction, and shareholder value (usually measured by the
Company stock price). Individual performance is measured to specific objectives
relevant to the individual's position and a specific time frame.

These criteria are usually related to a fiscal year time period, but may,
in some cases, be measured over a shorter or longer time frame.

The processes used by the Compensation Committee include the following
steps:

1. The Compensation Committee periodically receives information comparing
the Company's pay levels to other companies in similar industries,
other leading companies (regardless of industry) and competitors.
Primarily national and regional compensation surveys are used.

2. At or near the start of each evaluation cycle, the Compensation
Committee meets with the Chief Executive Officer to review, revise as
needed, and agree on the performance objectives set for the other
executives reporting to the Chief Executive Officer. The Chief
Executive Officer and Compensation Committee jointly set the Company
objectives to be used. The business unit and individual objectives are
formulated jointly by the Chief Executive Officer and the specific
individual. The Compensation Committee also, with the Chief Executive
Officer, jointly establishes and agrees on their respective
performance objectives.

3. Throughout the performance cycle review, feedback is provided by the
Chief Executive Officer, the Compensation Committee and full Board, as
appropriate.

4. At the end of the performance cycle, the Chief Executive Officer
evaluates each executive's relative success in meeting the performance
goals. The Chief Executive Officer makes recommendations on salary,
bonus and stock options, utilizing the comparative results as a
factor. Also included in the decision criteria are subjective factors
such as teamwork, leadership contributions and ongoing changes in the
business climate. The Chief Executive Officer reviews the
recommendations and obtains Compensation Committee approval. The
Compensation Committee also determines the level of salary and bonus
and the terms of stock option grants for the Chief Executive Officer.

5. The final evaluations and compensation decisions are discussed with
each executive by the Chief Executive Officer or Compensation
Committee, as appropriate.

William W.R. Elder has served as Chairman, President and Chief Executive
Officer since April 1998. In determining Mr. Elder's base salary and long-term
incentive compensation for 2003, the Compensation Committee considered both the
Company's performance and Mr. Elder's individual performance by the same
measures described above for determining executive compensation. No cash bonuses
were paid to Mr. Elder in fiscal year 2003.

The Compensation Committee feels that the compensation vehicles used by the
Company, generally administered through the process as outlined above, provide a
fair and balanced executive compensation program related to the proper business
issues. In addition, it should be noted that compensation vehicles will be
reviewed and, as appropriate, revised in order to retain and attract new
executives in addition to rewarding performance on the job.

Respectfully submitted by:

Mario M. Rosati
Robert J. Richardson

PERFORMANCE GRAPH

The following graph shows a comparison of cumulative total shareholder
return among the Company, the NASDAQ Stock Market-US Index, and the RDG
Technology Index for the period from December 31, 1998 (the last trading day
before the beginning of the Company's 1999 Fiscal Year) through 2003 Fiscal Year
End for the Company. The graph assumes that $100 was invested in the Company's
common stock, in the NASDAQ Stock Market-US Index, and the RDG Technology Index
on December 31, 1998 and all dividends were reinvested. Historic stock price
performance is not necessarily indicative of future stock price performance.

Cumulative Total Return
----------------------------------------------
12/98 12/99 12/00 12/01 12/02 12/03

GENUS, INC 100.00 436.38 154.58 235.65 222.07 581.85
NASDAQ STOCK MARKET (U.S.) 100.00 190.62 127.67 70.42 64.84 91.16
RDG TECHNOLOGY COMPOSITE 100.00 157.96 117.38 104.39 76.77 104.01

The information contained above under the captions "Compensation Committee
Report," "Audit Committee Report" and "Performance Graph" shall not be deemed to
be "soliciting material" or to be "filed" with the SEC, nor will such
information be incorporated by reference into any future SEC filing except to
the extent that Genus specifically incorporates it by reference into such
filing.

PROPOSAL TWO

RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS

The Board of Directors has selected PricewaterhouseCoopers LLP to audit our
financial statements for the fiscal year ending December 31, 2004. The decision
of the Board of Directors to appoint PricewaterhouseCoopers LLP was based on the
recommendation of the Audit Committee. Before making its recommendation to the
Board of Directors, the Audit Committee carefully considered that firm's
qualifications as independent auditors. This included a review of the
qualifications of the engagement team, the quality control procedures the firm
has established, and any issues raised by the most recent quality control review
of the firm; as well as its reputation for integrity and competence in the
fields of accounting and auditing. The Audit Committee's review also included
matters required to be considered under the SEC's Rules on Auditor Independence,
including the nature and extent of non-audit services, to ensure that they will
not impair the independence of the auditors. The Audit Committee expressed its
satisfaction with PricewaterhouseCoopers LLP in all of these respects.

Although ratification by shareholders is not required by law, the Board of
Directors has determined that it is desirable to request approval of this
selection by the shareholders. Notwithstanding its selection, the Board of
Directors, in its discretion, may appoint new independent auditors at any time
during the year if the Board of Directors believes that such a change would be
in the best interest of Genus and its shareholders. If the shareholders do not
ratify the appointment of PricewaterhouseCoopers LLP, the Board of Directors may
reconsider its selection.

PricewaterhouseCoopers LLP was first appointed in fiscal year 1982, and has
audited our financial statements for each fiscal year following its appointment.
The Board of Directors expects that representatives of PricewaterhouseCoopers
LLP will be present at the Annual Meeting to respond to appropriate questions
and to make a statement if they so desire.

OTHER MATTERS

The Company knows of no other matters to be submitted to the meeting. If
any other matters properly come before the meeting, it is the intention of the
persons named in the enclosed form of Proxy to vote the shares they represent as
the Board of Directors may recommend.

THE BOARD OF DIRECTORS
Dated: April 29, 2004

APPENDIX A
----------
CHARTER FOR THE
NOMINATING COMMITTEE OF
GENUS, INC.
PURPOSE:

The purpose of the Nominating Committee is to ensure that the Board of Directors
is properly constituted to meet its fiduciary obligations to shareholders and
the Company and that the Company has and follows appropriate governance
standards. To carry out this purpose, the Nominating Committee shall: (1) assist
the board by identifying prospective director nominees and to recommend to the
board the director nominees for the next annual meeting of shareholders; (2)
develop and recommend to the board the governance principles applicable to the
Company; (3) oversee the evaluation of the board and management; and (4)
recommend to the board director nominees for each committee.

COMMITTEE MEMBERSHIP AND ORGANIZATION:

- The Nominating Committee shall be comprised of no fewer than two
(2) members.

- The members of the Nominating Committee shall meet the
independence requirements of the Nasdaq Stock Market.

- The members of the Nominating Committee shall be appointed and
replaced by the board.

COMMITTEE RESPONSIBILITIES AND AUTHORITY:

- Evaluate the current composition, organization and governance of
the board and its committees, determine future requirements and
make recommendations to the board for approval.

- Determine on an annual basis desired board qualifications,
expertise and characteristics and conduct searches for potential
board members with corresponding attributes. Evaluate and propose
nominees for election to the board. In performing these tasks the
Nominating Committee shall have the sole authority to retain and
terminate any search firm to be used to identify director
candidates.

- Oversee the board performance evaluation process including
conducting surveys of director observations, suggestions and
preferences.

- Form and delegate authority to subcommittees when appropriate.

- Evaluate and make recommendations to the board concerning the
appointment of directors to board committees, the selection of
board committee chairs, and proposal of the board slate for
election. Consider shareholder nominees for election to the
board.

- Evaluate and recommend termination of membership of individual
directors in accordance with the board's governance principles,
for cause or for other appropriate reasons.

- Conduct an annual review on succession planning, report its
findings and recommendations to the board, and work with the
board in evaluating potential successors to executive management
positions.

- Coordinate and approve board and committee meeting schedules.

- Make regular reports to the board.

- Review and re-examine this Charter annually and make
recommendations to the board for any proposed changes.

- Annual review and evaluate its own performance.

- In performing its responsibilities, the Nominating Committee
shall have the authority to obtain advice, reports or opinions
from internal or external counsel and expert advisors.

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

GENUS, INC.

2004 ANNUAL MEETING OF SHAREHOLDERS

The undersigned shareholder of GENUS, INC., a California corporation (the
"Company"), hereby acknowledges receipt of the Notice of Annual Meeting of
Shareholders and Proxy Statement, each dated April 29, 2004, and hereby appoints
William W.R. Elder and Shum Mukherjee proxies and attorneys-in-fact, with full
power of substitution, on behalf and in the name of the undersigned, to
represent the undersigned at the 2004 Annual Meeting of Shareholders of Genus,
Inc. to be held on Thursday, June 10, 2004 at 10:00 a.m., local time, at the
Company's principal executive offices at 1139 Karlstad Drive in Sunnyvale,
California 94089, and any continuation(s) or adjournment(s) thereof, and to
vote all shares of common stock which the undersigned would be entitled to vote
if then and there personally present, on the matters set forth below.

- FOLD AND DETACH HERE -

Please mark your
choice like this [X]

________________
COMMON

FOR all nominees listed WITHHOLD authority to vote
below (except as indicated) for all nominees listed below.

1. Election of directors: [ ] [ ]

IF YOU WISH TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE,
STRIKE A LINE THROUGH THAT NOMINEE'S NAME IN THE LIST BELOW:

William W.R. Elder, Todd S. Myhre, G. Frederick Forsyth, Mario M. Rosati,
and Robert J. Richardson

2. Proposal to ratify the appointment of PricewaterhouseCoopers LLP as the
independent public accountants of the Company's financial statements for
the fiscal year ending December 31, 2004.

FOR AGAINST ABSTAIN

[ ] [ ] [ ]

3. In the discretion of the proxy holders, upon such other matter or matters
which may properly come before the meeting and any continuation(s) or
adjournment(s) thereof.

FOR AGAINST ABSTAIN

[ ] [ ] [ ]

THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO CONTRARY DIRECTION IS
INDICATED, WILL BE VOTED FOR THE ELECTION OF DIRECTORS, FOR THE
RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS
INDEPENDENT PUBLIC ACCOUNTANTS, AND IN THE DISCRETION OF THE PROXY HOLDERS,
UPON SUCH OTHER MATTER OR MATTERS WHICH MAY PROPERLY COME BEFORE THE
MEETING AND ANY CONTINUATION(S) OR ADJOURNMENT(S) THEREOF.

Signature(s) _______________________________________ Date __________, 2004

(This Proxy should be dated, signed by the shareholder(s) exactly as his or her
name appears hereon, and returned promptly in the enclosed envelope. Persons
signing in a fiduciary capacity should so indicate. If shares are held by joint
tenants or as community property, both should sign.)

- FOLD AND DETACH HERE -